Norway Dna Sequencing Market Size & Outlook, 2023-2030
Norway dna sequencing market, 2018-2030 (US$M)
Related Markets
Norway dna sequencing market highlights
- The Norway dna sequencing market generated a revenue of USD 86.1 million in 2023 and is expected to reach USD 182.0 million by 2030.
- The Norway market is expected to grow at a CAGR of 11.3% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Dna sequencing market data book summary
| Market revenue in 2023 | USD 86.1 million |
| Market revenue in 2030 | USD 182.0 million |
| Growth rate | 11.3% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
Other key industry trends
- In terms of revenue, Norway accounted for 0.7% of the global dna sequencing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany dna sequencing market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 3,667.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Sequencing Market Scope
DNA Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway dna sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 49.59% in 2023. Horizon Databook has segmented the Norway dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
The Norwegian Sequencing Centre (NSC) was founded in 2009 to make high-throughput sequencing capabilities available to Norwegian research community. A number of organizations, including Health South-East, the University of Oslo, and the Norwegian Research Council, have provided funding.
Furthermore, in December 2021, Illumina, Inc. announced supporting Norway's Precision Medicine Study. The study aims to evaluate the effectiveness of Comprehensive Genomic Profiling (CGP) based on blood samples for cancer therapy selection.
Reasons to subscribe to Norway dna sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway dna sequencing market databook
-
Our clientele includes a mix of dna sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Norway dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway dna sequencing market size, by product & service, 2018-2030 (US$M)
Norway DNA Sequencing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
